Pain experienced using two different methods of endometrial biopsy: A randomized controlled trial

Catherine Leclair, Joy K. Zia, Carmen M. Doom, Terry Morgan, Alison Edelman

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

OBJECTIVE: To compare patient-reported pain, provider-reported ease of use, and tissue sampling adequacy between endometrial biopsy instruments. METHODS: Women presenting for endometrial biopsy were randomized to either Pipelle or Explora curette. The primary outcome was patient-reported pain with biopsy as measured by a 100-mm visual analog scale. Secondary outcomes included the adequacy of biopsy sample and provider-reported ease of instrument use. RESULTS: Groups were similar in respect to age, parity, ethnicity, level of dysmenorrhea, menopausal status, and biopsy indication. The most common indication for biopsy was abnormal uterine bleeding. Subject reported pain with biopsy was similar between groups (Pipelle, 6.21±2.41 cm; Explora, 6.91±2.88 cm; P=.14), as was provider-reported ease of use. Although procedure length was significantly shorter for patients in the Pipelle group (4.05±1.48 minutes compared with 5.27±2.53 minutes; P=.007), 38% of Pipelle procedures required two or more passes to obtain a sample compared with only 9% using the Explora (P=.004). The Explora group had a higher proportion of adequate samples (97% compared with 91%; P=.33). CONCLUSION: Women's pain during endometrial biopsy does not differ by type of biopsy instrument used. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, www.clinicaltrials.gov NCT00613925.

Original languageEnglish (US)
Pages (from-to)636-641
Number of pages6
JournalObstetrics and Gynecology
Volume117
Issue number3
DOIs
StatePublished - Mar 2011

Fingerprint

Randomized Controlled Trials
Biopsy
Pain
Dysmenorrhea
Uterine Hemorrhage
Parity
Visual Analog Scale
Clinical Trials

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Pain experienced using two different methods of endometrial biopsy : A randomized controlled trial. / Leclair, Catherine; Zia, Joy K.; Doom, Carmen M.; Morgan, Terry; Edelman, Alison.

In: Obstetrics and Gynecology, Vol. 117, No. 3, 03.2011, p. 636-641.

Research output: Contribution to journalArticle

@article{d17c6920cffd4882927983a0aa641d47,
title = "Pain experienced using two different methods of endometrial biopsy: A randomized controlled trial",
abstract = "OBJECTIVE: To compare patient-reported pain, provider-reported ease of use, and tissue sampling adequacy between endometrial biopsy instruments. METHODS: Women presenting for endometrial biopsy were randomized to either Pipelle or Explora curette. The primary outcome was patient-reported pain with biopsy as measured by a 100-mm visual analog scale. Secondary outcomes included the adequacy of biopsy sample and provider-reported ease of instrument use. RESULTS: Groups were similar in respect to age, parity, ethnicity, level of dysmenorrhea, menopausal status, and biopsy indication. The most common indication for biopsy was abnormal uterine bleeding. Subject reported pain with biopsy was similar between groups (Pipelle, 6.21±2.41 cm; Explora, 6.91±2.88 cm; P=.14), as was provider-reported ease of use. Although procedure length was significantly shorter for patients in the Pipelle group (4.05±1.48 minutes compared with 5.27±2.53 minutes; P=.007), 38{\%} of Pipelle procedures required two or more passes to obtain a sample compared with only 9{\%} using the Explora (P=.004). The Explora group had a higher proportion of adequate samples (97{\%} compared with 91{\%}; P=.33). CONCLUSION: Women's pain during endometrial biopsy does not differ by type of biopsy instrument used. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, www.clinicaltrials.gov NCT00613925.",
author = "Catherine Leclair and Zia, {Joy K.} and Doom, {Carmen M.} and Terry Morgan and Alison Edelman",
year = "2011",
month = "3",
doi = "10.1097/AOG.0b013e31820ad45b",
language = "English (US)",
volume = "117",
pages = "636--641",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Pain experienced using two different methods of endometrial biopsy

T2 - A randomized controlled trial

AU - Leclair, Catherine

AU - Zia, Joy K.

AU - Doom, Carmen M.

AU - Morgan, Terry

AU - Edelman, Alison

PY - 2011/3

Y1 - 2011/3

N2 - OBJECTIVE: To compare patient-reported pain, provider-reported ease of use, and tissue sampling adequacy between endometrial biopsy instruments. METHODS: Women presenting for endometrial biopsy were randomized to either Pipelle or Explora curette. The primary outcome was patient-reported pain with biopsy as measured by a 100-mm visual analog scale. Secondary outcomes included the adequacy of biopsy sample and provider-reported ease of instrument use. RESULTS: Groups were similar in respect to age, parity, ethnicity, level of dysmenorrhea, menopausal status, and biopsy indication. The most common indication for biopsy was abnormal uterine bleeding. Subject reported pain with biopsy was similar between groups (Pipelle, 6.21±2.41 cm; Explora, 6.91±2.88 cm; P=.14), as was provider-reported ease of use. Although procedure length was significantly shorter for patients in the Pipelle group (4.05±1.48 minutes compared with 5.27±2.53 minutes; P=.007), 38% of Pipelle procedures required two or more passes to obtain a sample compared with only 9% using the Explora (P=.004). The Explora group had a higher proportion of adequate samples (97% compared with 91%; P=.33). CONCLUSION: Women's pain during endometrial biopsy does not differ by type of biopsy instrument used. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, www.clinicaltrials.gov NCT00613925.

AB - OBJECTIVE: To compare patient-reported pain, provider-reported ease of use, and tissue sampling adequacy between endometrial biopsy instruments. METHODS: Women presenting for endometrial biopsy were randomized to either Pipelle or Explora curette. The primary outcome was patient-reported pain with biopsy as measured by a 100-mm visual analog scale. Secondary outcomes included the adequacy of biopsy sample and provider-reported ease of instrument use. RESULTS: Groups were similar in respect to age, parity, ethnicity, level of dysmenorrhea, menopausal status, and biopsy indication. The most common indication for biopsy was abnormal uterine bleeding. Subject reported pain with biopsy was similar between groups (Pipelle, 6.21±2.41 cm; Explora, 6.91±2.88 cm; P=.14), as was provider-reported ease of use. Although procedure length was significantly shorter for patients in the Pipelle group (4.05±1.48 minutes compared with 5.27±2.53 minutes; P=.007), 38% of Pipelle procedures required two or more passes to obtain a sample compared with only 9% using the Explora (P=.004). The Explora group had a higher proportion of adequate samples (97% compared with 91%; P=.33). CONCLUSION: Women's pain during endometrial biopsy does not differ by type of biopsy instrument used. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, www.clinicaltrials.gov NCT00613925.

UR - http://www.scopus.com/inward/record.url?scp=79952027858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952027858&partnerID=8YFLogxK

U2 - 10.1097/AOG.0b013e31820ad45b

DO - 10.1097/AOG.0b013e31820ad45b

M3 - Article

C2 - 21343767

AN - SCOPUS:79952027858

VL - 117

SP - 636

EP - 641

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 3

ER -